Toshio Konomi

616 citations
12 papers · 464 indexed · h-index 9
Topics
Microbial Natural Products and Biosynthesis (9 papers)Actinomycetales infections and treatment (5 papers)Steroid Chemistry and Biochemistry (3 papers)

In The Last Decade

Toshio Konomi

12 papers receiving 413 citations

Peers

Toshio Konomi
Comparison fields: 5 of 50
  • Pharmacology 308
  • Molecular Biology 242
  • Organic Chemistry 144
  • Molecular Medicine 68
  • Biotechnology 48
Replace Eiko Iguchi with:
Eiko Iguchi Japan
Norio Ezaki United Kingdom
J. I. CIALDELLA United States
L. Neipp Switzerland
R. Corbaz Switzerland
HELEN A. AX United States
SHOICHI AMANO United Kingdom
Hermann Führer Switzerland
Ann C. Horan United States
J. H. COATS United States
Toshio Konomi relative to Eiko Iguchi Japan Eiko Iguchi's profile →
Citations per field
00.5×1.5×1.8×
Eiko Iguchi · 1×
Citations per year

Countries citing papers authored by Toshio Konomi

Since Specialization
Citations

This map shows the geographic impact of Toshio Konomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshio Konomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshio Konomi more than expected).

Fields of papers citing papers by Toshio Konomi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshio Konomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshio Konomi. The network helps show where Toshio Konomi may publish in the future.

Co-authorship network of co-authors of Toshio Konomi

This figure shows the co-authorship network connecting the top 25 collaborators of Toshio Konomi. A scholar is included among the top collaborators of Toshio Konomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshio Konomi. Toshio Konomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 5
2 12
3 23
4 17
5 81
6 45
7 25
8 13
9 2
10 1
11 183
12 57

About Toshio Konomi

Toshio Konomi is a scholar working on Microbiology, Pharmacology and Biotechnology, having authored 12 papers that have together received 464 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (9 papers), Actinomycetales infections and treatment (5 papers) and Steroid Chemistry and Biochemistry (3 papers). The work is most often cited by research in Microbiology (39 citations), Pharmacology (308 citations) and Molecular Medicine (68 citations). Toshio Konomi has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Hiroshi Imanaka, Heiichi Sakai, HATSUO AOKI, JUNJI HOSODA, A. L. Demain, Eiko Iguchi, MASANOBU KOHSAKA, Jack E. Baldwin, Norma Hunt and Masao Yoshida. Their work appears in journals such as Proceedings of the National Academy of Sciences, FEMS Microbiology Letters and The Journal of Antibiotics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026